| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Piper Sandler analyst Paul Newsome maintains ProAssurance (NYSE:PRA) with a Neutral and raises the price target from $18 to ...
ProAssurance (NYSE:PRA) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.20 by ...
Citizens Capital Markets analyst Matthew Carletti downgrades ProAssurance (NYSE:PRA) from Market Outperform to Market Perform.
ProAssurance stock is moving higher on Thursday after the company announced it will be acquired by The Doctors Company, a medic...